Rajesh Devraj
@r_devraj
CEO, Rectify Pharma. Venture Partner, Atlas Venture. Experienced drug hunter, company builder, entrepreneur, recovering large pharma exec.
Вам может понравиться
Repost far and wide! Thanks for the narrative @simonmaechling
This “study” looks serious. It has an abstract, authors, even affiliations. But read it carefully - it’s pure satire. And it brilliantly exposes one of the biggest flaws in bad science: confusing correlation with causation. “Over 90% of autistic children consumed breast milk or…
This “study” looks serious. It has an abstract, authors, even affiliations. But read it carefully - it’s pure satire. And it brilliantly exposes one of the biggest flaws in bad science: confusing correlation with causation. “Over 90% of autistic children consumed breast milk or…
In April, biotech was the most hated sector of all time. I looked back today and found these two pieces that bucked the trend. Credit @david_wainer and @adamfeuerstein.
Here is my advice to pregnant women Talk to your doctor about the risks and benefits for you and your baby from any medicine Do not take advice from politicians
Federer spotted at Stanford👀👀 lachlan.ming IG
" Greatness on The Farm 🌲" Stanford Men’s Tennis IG
King is holding court y’all.
Yep. This👇🏼
USA is strong because of the people, not the government. We are a nation of individuals who either got thrown out or chose to come here. A nation founded by immigrants. Freedom of speech. Of religion. To not be oppressed by government. Celebrate our freedom.
#ICYMI: Our CEO, @r_devraj, joined Sam Kessel on the @NucleateHQ podcast to talk target validation, PFMs, and the mission driving Rectify’s work in #PSC and beyond. 🎧 Tune in: bit.ly/4dYMuqQ
🎙️Building Biotech: From the Bench to the Boardroom Raj Devraj (CEO @RectifyPharma, Venture Partner @AtlasVC) shares hard-won lessons on capital efficiency, target validation & startup leadership. A must-listen for biotech founders. 👇 signal.nucleate.xyz/building-biote…
At #EASLCongress 2025 we’re presenting data that demonstrates the potential for a B4/BSEP PFM to address the core pathology of multiple liver & biliary diseases, incl. #PrimarySclerosingCholangitis. Read more: bit.ly/4m8O2lP
We’re attending the 62nd @ERAkidney Congress June 4–7! We’ll present new transitional data from our cardio-renal-metabolic program addressing critical unmet needs in kidney health. More on our presentation: bit.ly/4kvrMRM #ERA25
Thanks for the opportunity @Xtalks to discuss our lead program for #PSC and our #PFM platform that allows us to discover and develop oral, small molecule drugs to rectify membrane protein dysfunction.
Thanks for the opportunity @LongwoodLeaders to converse with a distinguished panel of execs who are balancing and derisking novel science, building novel platforms and bringing differentiated products to serve patients. @LongwoodFund @RectifyPharma
Insightful conversation on #drugdiscovery sciences with biotech CEOs Dee Datta Switch Therapeutics, Brent Vaughan, JJ Kang Appia Bio, Dominique Verhelle NextRNA Therapeutics, @r_devraj @RectifyPharma #longwoodhealthcareleaders #JPM25
Investors in Padlock Therapeutics sue Bristol Myers Squibb $BMY over ‘milestone’ payments The dark side of so-called biobucks deals, featuring @michael_gilman statnews.com/2024/12/12/pad…
I could not agree more with @JackScannell13
Furthermore, the productivity loss from small decrements in test validity (e.g., by adapting the test to reduce cycle time or to increase throughput) can swamp large gains in brute-force efficiency. Quality beats quantity. 6/8
Furthermore, the productivity loss from small decrements in test validity (e.g., by adapting the test to reduce cycle time or to increase throughput) can swamp large gains in brute-force efficiency. Quality beats quantity. 6/8
Thanks @BiotechTVHQ for the opportunity to discuss our #PFM approach and data with our lead candidate that supports treatment of devastating hepatobiliary diseases like PSC by reducing both cholangitis and cholestasis.
𝐓𝐡𝐞 𝐋𝐢𝐯𝐞𝐫 𝐌𝐞𝐞𝐭𝐢𝐧𝐠: @RectifyPharma presented preclinical data supporting its hypothesis of improving the function of dysfunctional membrane proteins: ABCB4 and BSEP. #TLM24 Full video: biotechtv.com/post/rectify-p…
Pure CLASS! No surprises here.
Vamos, @RafaelNadal! As you get ready to graduate from tennis, I’ve got a few things to share before I maybe get emotional. Let’s start with the obvious: you beat me—a lot. More than I managed to beat you. You challenged me in ways no one else could. On clay, it felt like I…
United States Тренды
- 1. Maxey 6,671 posts
- 2. Maxey 6,671 posts
- 3. Sixers 17.3K posts
- 4. #AEWDynamite 20K posts
- 5. Knicks 30.3K posts
- 6. Embiid 11.5K posts
- 7. Clippers 6,839 posts
- 8. Celtics 24.2K posts
- 9. Wemby 9,438 posts
- 10. #Survivor49 2,327 posts
- 11. Pritchard 1,846 posts
- 12. Cavs 15.4K posts
- 13. Donovan Mitchell 2,688 posts
- 14. #SistasOnBET 2,237 posts
- 15. Pistons 5,687 posts
- 16. Brunson 6,733 posts
- 17. #NewYorkForever 3,079 posts
- 18. Athena 8,120 posts
- 19. Hornets 9,703 posts
- 20. Jarrett Allen 1,142 posts
Вам может понравиться
-
Jeb Keiper
@JebKeiper -
Rosana Kapeller
@KapellerRosana -
Nello Mainolfi
@NelloMainolfi -
Alex Harding
@AlexHarding7 -
Jo Viney (she/her)
@76viney -
Ankit Mahadevia
@AMahadevia -
Art Krieg
@ArtKrieg -
Michael Gladstone
@MikeNGladstone -
David Schenkein
@schenkein -
Christoph Westphal
@drcwestphal -
Carol Suh
@carolysuh -
Ron Renaud
@biotech1969 -
George Vlasuk
@GVlasuk -
Vipin Suri
@VipinSuri4 -
Rick Lundberg
@RickLundberg
Something went wrong.
Something went wrong.